Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

1.470

-0.150 (-9.26%)

Jul 28, 2026, 1:50 PM EDT - Market open

Clearmind Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	-7.9	-3.86	-5.25	-8.62	-6.89	-2.73
Depreciation & Amortization	0.05	0.05	0.05	0.06	0.08	0
Stock-Based Compensation	1.74	0.81	1	0.83	1.21	0.62
Other Adjustments	-0.82	-1.69	-0.52	2.42	0.64	0.01
Change in Receivables	-0.09	0.02	0.06	-0.15	0.02	-0.12
Changes in Accounts Payable	0.23	0.08	-0.2	-0.62	0.91	0.25
Changes in Other Operating Activities	-0.21	-0.14	0	-0.19	0.3	-0.12
Operating Cash Flow	-6.22	-4.73	-4.86	-6.3	-3.72	-2.08
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Capital Expenditures	-	-	-	-	-0.01	-0.02
Purchases of Intangible Assets	-	-	-	-	-	-0.15
Purchases of Investments	-	-0.71	-0.35	-	-	-
Proceeds from Sale of Investments	0.1	0.19	0.08	-	-	-
Other Investing Activities	-	-0.01	0.03	-0.03	-	-0.01
Investing Cash Flow	-1.06	-0.54	-0.24	-0.03	-0.01	-0.18

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Long-Term Debt Issued	-	2.25	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-	2.25	-	-	-	-
Issuance of Common Stock	7.47	0.42	6.3	11.71	0.58	5.39
Net Common Stock Issued (Repurchased)	7.47	0.42	6.3	11.71	0.58	5.39
Other Financing Activities	-0.05	-0.04	-0.04	-0.04	-0.07	-
Financing Cash Flow	14.22	2.62	6.25	11.66	0.51	5.39

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Foreign Exchange Rate Adjustments	0.01	0	-0.01	-0.04	-0.02	-
Net Cash Flow	6.94	-2.65	1.15	5.3	-3.24	3.13

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Free Cash Flow	-6.22	-4.73	-4.86	-6.3	-3.73	-2.09
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-55.92	-372.52	-	-	-	-
Levered Free Cash Flow	-7.14	-1.61	-5.4	-9.38	-5.6	-2.61
Unlevered Free Cash Flow	-8.04	-5.78	-6.33	-7.07	-4.98	-2.57

SEC Filings: 10-K · 10-Q